Estrogen receptor β activation impairs prostatic regeneration by inducing apoptosis in murine and human stem/progenitor enriched cell populations
- PMID: 22808245
- PMCID: PMC3393688
- DOI: 10.1371/journal.pone.0040732
Estrogen receptor β activation impairs prostatic regeneration by inducing apoptosis in murine and human stem/progenitor enriched cell populations
Abstract
Androgen depletion is the primary treatment for prostate disease; however, it fails to target residual castrate-resistant cells that are regenerative and cells of origin of prostate cancer. Estrogens, like androgens, regulate survival in prostatic cells, and the goal of this study was to determine the advantages of selective activation of estrogen receptor β (ERβ) to induce cell death in stem cells that are castrate-resistant. Here we show two cycles of short-term ERβ agonist (8β-VE2) administration this treatment impairs regeneration, causing cystic atrophy that correlates with sustained depletion of p63+ basal cells. Furthermore, agonist treatment attenuates clonogenicity and self-renewal of murine prostatic stem/progenitor cells and depletes both murine (Lin(-)Sca1(+)CD49f(hi)) and human (CD49f(hi)Trop2(hi)) prostatic basal cells. Finally, we demonstrate the combined added benefits of selective stimulation of ERβ, including the induction of cell death in quiescent post-castration tissues. Subsequent to castration ERβ-induces further apoptosis in basal, luminal and intermediate cells. Our results reveal a novel benefit of ERβ activation for prostate disease and suggest that combining selective activation of ERβ with androgen-deprivation may be a feasible strategy to target stem cells implicated in the origin of prostatic disease.
Conflict of interest statement
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3393688/bin/pone.0040732.g001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3393688/bin/pone.0040732.g002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3393688/bin/pone.0040732.g003.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3393688/bin/pone.0040732.g004.gif)
Similar articles
-
A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumours.J Pathol. 2017 Sep;243(1):51-64. doi: 10.1002/path.4924. Epub 2017 Jul 28. J Pathol. 2017. PMID: 28603917
-
Protein profile of basal prostate epithelial progenitor cells--stage-specific embryonal antigen 4 expressing cells have enhanced regenerative potential in vivo.J Cell Mol Med. 2016 Apr;20(4):721-30. doi: 10.1111/jcmm.12785. Epub 2016 Feb 5. J Cell Mol Med. 2016. PMID: 26849468 Free PMC article.
-
Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated.Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3123-8. doi: 10.1073/pnas.0905524107. Epub 2010 Feb 1. Proc Natl Acad Sci U S A. 2010. PMID: 20133657 Free PMC article.
-
Progenitor cells for the prostate epithelium: roles in development, regeneration, and cancer.Cold Spring Harb Symp Quant Biol. 2008;73:529-38. doi: 10.1101/sqb.2008.73.050. Epub 2009 Jan 15. Cold Spring Harb Symp Quant Biol. 2008. PMID: 19150960 Review.
-
The role of Eralpha and ERbeta in the prostate: insights from genetic models and isoform-selective ligands.Ernst Schering Found Symp Proc. 2006;(1):131-47. doi: 10.1007/2789_2006_020. Ernst Schering Found Symp Proc. 2006. PMID: 17824175 Review.
Cited by
-
Stem Cells as Target for Prostate cancer Therapy: Opportunities and Challenges.Stem Cell Rev Rep. 2022 Dec;18(8):2833-2851. doi: 10.1007/s12015-022-10437-6. Epub 2022 Aug 11. Stem Cell Rev Rep. 2022. PMID: 35951166 Free PMC article. Review.
-
Therapeutic Targeting of Ovarian Cancer Stem Cells Using Estrogen Receptor Beta Agonist.Int J Mol Sci. 2022 Jun 28;23(13):7159. doi: 10.3390/ijms23137159. Int J Mol Sci. 2022. PMID: 35806169 Free PMC article.
-
Unexplored Functions of Sex Hormones in Glioblastoma Cancer Stem Cells.Endocrinology. 2022 Mar 1;163(3):bqac002. doi: 10.1210/endocr/bqac002. Endocrinology. 2022. PMID: 35023543 Free PMC article. Review.
-
Animal Models of Temporomandibular Disorder.J Pain Res. 2021 May 26;14:1415-1430. doi: 10.2147/JPR.S303536. eCollection 2021. J Pain Res. 2021. PMID: 34079358 Free PMC article. Review.
-
Estrogen Receptor Beta: The Promising Biomarker and Potential Target in Metastases.Int J Mol Sci. 2021 Feb 6;22(4):1656. doi: 10.3390/ijms22041656. Int J Mol Sci. 2021. PMID: 33562134 Free PMC article. Review.
References
-
- Huggins C, Hodges CV. Studies on prostatic cancer. The effect of castration, of estrogen and of androgen interaction on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res. 1941;1:293–297. - PubMed
-
- Goldenberg SL, Fenster HN, Perler Z, McLoughlin MG. Disseminated intravascular coagulation in carcinoma of prostate: role of estrogen therapy. Urology. 1983;22:130–132. - PubMed
-
- Harris HA. Estrogen receptor-β: Recent lessons from in vivo studies. Mol Endocrinol. 2006. - PubMed
-
- Thomas C, Gustafsson JA. The different roles of ER subtypes in cancer biology and therapy. Nature reviews Cancer. 2011;11:597–608. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous